Filing Details
- Accession Number:
- 0001127602-12-023048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-27 18:34:04
- Reporting Period:
- 2012-07-26
- Filing Date:
- 2012-07-27
- Accepted Time:
- 2012-07-27 18:34:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1298861 | M Trevor Jones | 2525 Dupont Drive Irvine CA 92612 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-07-26 | 1,500 | $84.70 | 20,327 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 10, 2012.
- Includes 4,800 shares of the Issuer's common stock underlying the RSUs awarded.
- Includes shares issued pursuant to the dividend equivalent rights, exempt transaction under Rule 16a-11.